A Trial of Varenicline for E-cigarette Cessation

Recruiting

Phase 2

VareniclineA Trial of Varenicline for E-cigarette Cessation

Sponsor:

Yale University

Code:

NCT07040566

Conditions

E-cigarette Use

Vaping

Nicotine Dependence

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Varenicline 1mg BID

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-10-10. This information was provided to ClinicalTrials.gov by Yale University on 2025-10-07.